These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2107512)

  • 21. Studies on the mechanism of bacterial resistance to complement-mediated killing. III. C5b-9 deposits stably on rough and type 7 S. pneumoniae without causing bacterial killing.
    Joiner K; Brown E; Hammer C; Warren K; Frank M
    J Immunol; 1983 Feb; 130(2):845-9. PubMed ID: 6848598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement-mediated killing of susceptible gram-negative bacteria: an elusive mechanism.
    Taylor PW
    Exp Clin Immunogenet; 1992; 9(1):48-56. PubMed ID: 1642903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C5b-7 and C5b-8 precursors of the membrane attack complex (C5b-9) are effective killers of E. coli J5 during serum incubation.
    Bloch EF; Knight EM; Carmon T; McDonald-Pinkett S; Carter J; Boomer A; Ogunfusika M; Petersen M; Famakin B; Aniagolu J; Walker J; Gant R; Walters CS; Gaither TA
    Immunol Invest; 1997 Jun; 26(4):409-19. PubMed ID: 9246562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement-mediated inhibition of function in complement-resistant Escherichia coli.
    Dankert JR
    J Immunol; 1989 Mar; 142(5):1591-5. PubMed ID: 2645364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Supplemental complement component C9 enhances the capacity of neonatal serum to kill multiple isolates of pathogenic Escherichia coli.
    Lassiter HA; Wilson JL; Feldhoff RC; Hoffpauir JM; Klueber KM
    Pediatr Res; 1994 Apr; 35(4 Pt 1):389-96. PubMed ID: 8047374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymerization of C9 enhances bacterial cell envelope damage and killing by membrane attack complex pores.
    Doorduijn DJ; Heesterbeek DAC; Ruyken M; de Haas CJC; Stapels DAC; Aerts PC; Rooijakkers SHM; Bardoel BW
    PLoS Pathog; 2021 Nov; 17(11):e1010051. PubMed ID: 34752492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacterial killing by complement. C9-mediated killing in the absence of C5b-8.
    Dankert JR; Esser AF
    Biochem J; 1987 Jun; 244(2):393-9. PubMed ID: 3311029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of the complement Membrane Attack Complex to the bactericidal activity of human serum.
    Berends ET; Mohan S; Miellet WR; Ruyken M; Rooijakkers SH
    Mol Immunol; 2015 Jun; 65(2):328-35. PubMed ID: 25725315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inherited deficiency of the ninth component of complement in man.
    Lint TF; Zeitz HJ; Gewurz H
    J Immunol; 1980 Nov; 125(5):2252-7. PubMed ID: 7430628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonal antibodies directed against gonococcal protein I vary in bactericidal activity.
    Joiner KA; Warren KA; Tam M; Frank MM
    J Immunol; 1985 May; 134(5):3411-9. PubMed ID: 3920319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of C9 polymerization within the SC5b-9 complex of complement by S-protein.
    Podack ER; Preissner KT; Müller-Eberhard HJ
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():89-96. PubMed ID: 6587746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibodies specific to surface antigens are not effective in complement-mediated killing of Haemophilus ducreyi.
    Frisk A; Ahmed HJ; Van Dyck E; Lagergård T
    Microb Pathog; 1998 Aug; 25(2):67-75. PubMed ID: 9712686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9.
    Puentes SM; Da Silva RP; Sacks DL; Hammer CH; Joiner KA
    J Immunol; 1990 Dec; 145(12):4311-6. PubMed ID: 2147941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human IgA1 initiates complement-mediated killing of Neisseria meningitidis.
    Jarvis GA; Griffiss JM
    J Immunol; 1989 Sep; 143(5):1703-9. PubMed ID: 2474610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacterial killing and inhibition of inner membrane activity by C5b-9 complexes as a function of the sequential addition of C9 to C5b-8 sites.
    MacKay SL; Dankert JR
    J Immunol; 1990 Nov; 145(10):3367-71. PubMed ID: 2230122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The membrane attack complex of complement: C5b-8 complex as accelerator of C9 polymerization.
    Tschopp J; Podack ER; Müller-Eberhard HJ
    J Immunol; 1985 Jan; 134(1):495-9. PubMed ID: 3964819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement-mediated serum cytotoxicity for Leishmania major amastigotes: killing by serum deficient in early components of the membrane attack complex.
    Hoover DL; Berger M; Hammer CH; Meltzer MS
    J Immunol; 1985 Jul; 135(1):570-4. PubMed ID: 3998474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8.
    Lehto T; Meri S
    J Immunol; 1993 Nov; 151(9):4941-9. PubMed ID: 7691959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Homozygous C7 defect in a German family].
    Pietsch H; Raab K; Lalyko K; Wahn V
    Monatsschr Kinderheilkd; 1993 May; 141(5):412-5. PubMed ID: 8326961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A synthetic peptide from complement protein C9 binds to CD59 and enhances lysis of human erythrocytes by C5b-9.
    Tomlinson S; Whitlow MB; Nussenzweig V
    J Immunol; 1994 Feb; 152(4):1927-34. PubMed ID: 7509832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.